Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.

Abstract

BACKGROUND Botulinum toxin type B (BTX-B; Myobloc) has recently been introduced for the treatment of dynamic rhytides. This serotype is structurally similar to botulinum toxin type A (BTX-A; Botox) and appears to produce equivalent muscular paralysis. Because of the fact that some patients may become resistant to the effects of BTX-A with its continued use… (More)

Topics

1 Figure or Table

Cite this paper

@article{Alster2003BotulinumTT, title={Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.}, author={Tina S. Alster and Jason R Lupton}, journal={Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]}, year={2003}, volume={29 5}, pages={516-8} }